Follicular adenoma is the most common benign solid neoplasm of the thyroid gland, originating from follicular cells. It is a well-defined, usually solitary tumor completely surrounded by a thin fibrous capsule. It constitutes approximately 5-10% of all thyroid nodules and occurs 3-4 times more frequently in women than men, with peak incidence between ages 30-50. The greatest clinical challenge is its inability to be distinguished from follicular carcinoma by imaging or cytology — differentiation can only be made on histopathological examination based on the presence or absence of capsular and/or vascular invasion. Therefore, fine-needle aspiration biopsy (FNAB) results are reported as 'follicular neoplasm/suspicious for follicular neoplasm' (Bethesda IV), and surgery (diagnostic lobectomy) is recommended.
Age Range
20-60
Peak Age
40
Gender
Female predominant
Prevalence
Common
Follicular adenoma develops from monoclonal proliferation of thyroid follicular epithelial cells. At the genetic level, the most frequent findings are RAS mutations (N-RAS, H-RAS, K-RAS — in 20-40% of cases) and PAX8-PPARγ gene rearrangements (in 10-30% of cases) — importantly, the same genetic alterations are also found in follicular carcinoma, positioning both entities at two ends of the same spectrum. A thin fibrous capsule develops around the tumor: this capsule forms a barrier between tumor cells and normal thyroid parenchyma. Capsule integrity is the fundamental criterion distinguishing adenoma from carcinoma — capsular invasion = follicular carcinoma. On ultrasonography, the halo (sonolucent pericapsular rim) reflects this fibrous capsule and compressed peripheral vessels. The adenoma's rich vascularity results from the tumor developing its own capillary network: compressed capsular vessels produce perinodular Doppler signal, while intranodular vessels represent newly formed tumor vasculature. Over time, cystic degeneration, hemorrhage, and calcification may develop due to central ischemia and necrosis — these changes cause heterogeneity on imaging.
Thin, complete, sonolucent or hyperechoic rim around the nodule — representing the fibrous capsule and compressed peripheral vessels. A complete and regular halo indicates intact capsule and is a characteristic finding of follicular adenoma. However, an incomplete or irregular halo raises suspicion of capsular invasion and increases the possibility of follicular carcinoma. In practice, the presence of halo alone does not prove benignity — halo can also be seen in minimally invasive follicular carcinoma.
Well-defined, solid, homogeneously hypoechoic (slightly lower echogenicity than surrounding parenchyma) nodule. Thin complete hyperechoic rim (halo) represents the capsule. The halo sign indicates intact capsule and separation from surrounding tissue — however, intact capsule may also be present in follicular carcinoma (minimally invasive type). The nodule is typically round or oval (wider-than-tall) shaped. Homogeneous internal structure is typical, but degenerative changes (cystic areas, calcification) in large adenomas may cause heterogeneity. Echogenicity level scores 2 points (hypoechoic) in TI-RADS v2017.
Report Sentence
A well-defined, solid, homogeneously hypoechoic nodule measuring …x…x… mm surrounded by a thin complete hyperechoic rim (halo) is identified in the right/left thyroid lobe, and follicular neoplasm should be considered (adenoma/carcinoma distinction is histopathological).
On color Doppler, follicular adenoma characteristically demonstrates a 'basket pattern': regular perinodular vascularity along the capsule. Intranodular vascularity is variable — minimal in small adenomas, prominent intranodular flow may be present in large adenomas. The perinodular basket pattern suggests intact capsule and preserved compressed peripheral vessels. However, this pattern can also be seen in minimally invasive follicular carcinoma. Prominent chaotic intranodular vascularity is more suggestive of malignancy.
Report Sentence
Color Doppler examination demonstrates regular perinodular vascularity along the capsule (basket pattern) around the nodule, consistent with a well-encapsulated neoplasm.
Follicular adenomas show variable uptake patterns on Tc-99m scintigraphy: 10-20% are hot (hyperfunctioning — uptake greater than surrounding parenchyma), while the majority appear as warm or cold nodules. Hot follicular adenoma may be autonomously functioning (toxic adenoma) and cause TSH suppression. Cold nodule increases malignancy suspicion but 85-90% of cold nodules are benign. Scintigraphy is not diagnostic in follicular adenoma — it is a functional assessment tool.
Report Sentence
On Tc-99m pertechnetate scintigraphy, significantly increased/decreased radiopharmaceutical uptake is noted in the area corresponding to the nodule in the right/left thyroid lobe.
On contrast-enhanced CT, follicular adenoma demonstrates homogeneous enhancement. On non-contrast images, it appears isodense or slightly hypodense relative to normal thyroid parenchyma. Prominent enhancement in the arterial phase reflects the adenoma's rich vascularity. The capsule may be visible as a thin low-density rim on contrast-enhanced studies. Cystic degeneration areas do not enhance. Mass effect on surrounding structures (trachea, esophagus) should be assessed in large adenomas. CT cannot distinguish follicular adenoma from carcinoma — capsular invasion is below CT resolution.
Report Sentence
On contrast-enhanced CT, a well-defined, homogeneously enhancing solid nodule measuring …x…x… mm surrounded by a thin capsule is identified in the right/left thyroid lobe, and follicular neoplasm should be considered.
On T2-weighted MR images, follicular adenoma shows iso- to hyperintense signal relative to normal thyroid parenchyma. The intact fibrous capsule appears as a thin hypointense rim on T2 — this results from the short T2 relaxation time of fibrous tissue. On T1-weighted images, the nodule is iso- to hypointense relative to parenchyma. Homogeneous enhancement is typical on contrast-enhanced studies. Diffusion restriction is generally absent or mild on DWI — however, DWI also cannot reliably distinguish adenoma from carcinoma.
Report Sentence
On MRI, the nodule in the right/left thyroid lobe demonstrates iso- to hyperintense signal on T2-weighted sequences relative to parenchyma, thin hypointense capsular rim, and homogeneous enhancement on contrast-enhanced sequences, consistent with a well-encapsulated follicular neoplasm.
Follicular adenoma is typically wider-than-tall (AP diameter < transverse diameter) in shape — reflecting benign growth pattern. Taller-than-wide shape (AP diameter > transverse diameter) scores 3 points in TI-RADS v2017 and increases malignancy suspicion. In adenomas, wider-than-tall shape represents regular capsular expansion and growth parallel to surrounding tissue planes. Oval or round morphology are the most commonly observed shapes.
Report Sentence
The nodule demonstrates wider-than-tall configuration (AP diameter < transverse diameter), consistent with a benign growth pattern.
Criteria
Composed of large, colloid-filled follicles. Similar to normal thyroid follicles but larger structures.
Distinct Features
Cystic areas may be more prominent on US, may resemble colloid nodule. Lower malignancy risk.
Criteria
Composed of small, tightly packed follicles. Cellular richness is prominent. Bethesda IV on FNAB.
Distinct Features
More solid and hypoechoic appearance on US. Most difficult subtype to differentiate from follicular carcinoma. Surgery recommended.
Criteria
TSH suppression + hot nodule on scintigraphy + surrounding suppression. Hyperthyroidism symptoms may be present.
Distinct Features
Markedly hot on scintigraphy, surrounding suppressed. Very low malignancy risk (<1%). Radioactive iodine therapy or surgery are options.
Criteria
Atypical histological features: increased mitotic activity, necrosis, large cell changes. NO capsular/vascular invasion.
Distinct Features
Cannot be distinguished from typical adenoma on imaging. Requires histopathological diagnosis. Close follow-up recommended.
Distinguishing Feature
Follicular carcinoma cannot be distinguished from adenoma by imaging or cytology — differentiation is made ONLY by demonstrating capsular and/or vascular invasion on histopathology. Incomplete/irregular halo increases invasion suspicion but is not definitive.
Distinguishing Feature
Colloid nodule demonstrates spongiform pattern and comet-tail artifact, tends to be predominantly cystic. Follicular adenoma is solid, hypoechoic, and encapsulated. Differentiation between colloid-rich large follicular adenoma and degenerated colloid nodule can be difficult.
Distinguishing Feature
Hurthle cell adenoma shows similar appearance to follicular adenoma but is typically more distinctly hypoechoic and more vascular (increased intranodular vascularity). Hurthle cell tumors may show more aggressive behavior and are always cold on scintigraphy (no RAI uptake).
Distinguishing Feature
Papillary carcinoma demonstrates microcalcifications (echogenic foci without comet-tail artifact), taller-than-wide shape, irregular margins, and marked hypoechogenicity. Follicular adenoma has smooth margins, capsule, and calcifications are typically absent or coarse type.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
specialist-referralWhen follicular adenoma is suspected (FNAB Bethesda IV: follicular neoplasm/suspicious for follicular neoplasm), surgery (diagnostic lobectomy) is recommended — because adenoma/carcinoma distinction can only be made histopathologically. After surgery, if no capsular/vascular invasion is found on pathology, the diagnosis is confirmed as benign follicular adenoma and no additional treatment is needed. If invasion is identified, follicular carcinoma is diagnosed and completion thyroidectomy + RAI therapy is planned. For hot/autonomous nodules, radioactive iodine therapy or thermal ablation may be considered as alternatives. In Bethesda III (atypical cells), molecular testing (Afirma, ThyroSeq) may guide surgical decision.
Follicular adenomas are benign tumors but cannot be definitively distinguished from follicular carcinoma on imaging. Therefore, diagnostic lobectomy is recommended in suspicious cases. FNA yields a 'follicular neoplasm' diagnosis but cannot differentiate benign from malignant.